New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 6, 2014
09:21 EDTJAZZJazz Pharmaceuticals thesis remains intact, says Cowen
Cowen said the thesis for Jazz Pharmaceuticals remains intact after the company posted solid Q2 results. The firm cited strong sales, in-line spending, and increased revenue guidance and would be buyers of the stock at what they call "very protected" levels. Cowen has a $190 price target on Jazz.
News For JAZZ From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 7, 2015
10:10 EDTJAZZJazz patent on Xyrem latest to be challenged by Kyle Bass
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use